GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $604,000 | -1.3% | 13,858 | -0.1% | 0.26% | +6.1% |
Q4 2021 | $612,000 | +13.1% | 13,875 | -2.1% | 0.25% | +4.2% |
Q3 2021 | $541,000 | -2.2% | 14,167 | +2.0% | 0.24% | -5.2% |
Q2 2021 | $553,000 | +14.3% | 13,887 | +2.4% | 0.25% | +4.6% |
Q1 2021 | $484,000 | +45.8% | 13,563 | +50.3% | 0.24% | +34.3% |
Q4 2020 | $332,000 | +5.1% | 9,023 | +7.6% | 0.18% | -6.8% |
Q3 2020 | $316,000 | 0.0% | 8,385 | +8.1% | 0.19% | -9.0% |
Q2 2020 | $316,000 | +12.1% | 7,755 | +4.3% | 0.21% | -3.7% |
Q1 2020 | $282,000 | -20.8% | 7,435 | -1.8% | 0.22% | -6.4% |
Q4 2019 | $356,000 | – | 7,575 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |